Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216599 · ClinicalTrials.gov registry record · NA
Photoacoustic Imaging of Foot Wound
A NA study of Foot Ulcer, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07216599: Recruiting NA study of Foot Ulcer, sponsored by State University of New York at Buffalo.
NCT07216599 is a NA study of Foot Ulcer that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 25 participants, below the 160-participant average among 12 other Foot Ulcer trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216599, a NA study of Foot Ulcer, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large-scale studies.
Primary Outcome
The ratio of cases received additional clinical assessment due to photoacoustic imaging results.
Conditions Studied
Interventions
- DEVICE Photoacoustic imaging and multispectral imaging
Study Locations (1)
New York
- UBMD Vascular Surgery - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07216599 shows while recruiting
NCT07216599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 160-participant average among 12 other Foot Ulcer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Photoacoustic imaging and multispectral imaging is the first listed.
NCT07216599 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07216599 about?
NCT07216599 is a clinical study titled "Photoacoustic Imaging of Foot Wound". This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., dr...
What is the current status of trial NCT07216599?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-10-28. Estimated completion is 2026-12-31.
What conditions does trial NCT07216599 study?
This clinical trial studies the following conditions: Foot Ulcer.
What interventions are being tested in trial NCT07216599?
The interventions under investigation include: Photoacoustic imaging and multispectral imaging (DEVICE).
Who is sponsoring clinical trial NCT07216599?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216599 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07216599's enrollment target sits among peer trials
25 13th of 12 the lowest of 12 other Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
RECRUITING · NA
-
Total Contact Soft Cast in Diabetic Foot Ulcers
RECRUITING · NA
-
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
RECRUITING · NA
-
Diabetic Foot Ulcer Imaging- Study 2
RECRUITING · NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI